Cargando…
Successful Sirolimus Treatment of Lymphangioleiomyomatosis in a Hepatitis B Virus Carrier
A 34-year-old woman experiencing shortness of breath was referred to our hospital. The patient was diagnosed with sporadic lymphangioleiomyomatosis based on the observation of bilateral diffuse multiple thin-walled cysts on computed tomography of the chest, chylous effusion, elevated serum vascular...
Autores principales: | Sonobe, Shoko, Arai, Toru, Tanimoto, Yasushi, Sugimoto, Chikatoshi, Kitaichi, Masanori, Akira, Masanori, Kasai, Takahiko, Hirose, Masaki, Inoue, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421154/ https://www.ncbi.nlm.nih.gov/pubmed/30333386 http://dx.doi.org/10.2169/internalmedicine.1329-18 |
Ejemplares similares
-
Comorbid connective tissue diseases and autoantibodies in lymphangioleiomyomatosis: a retrospective cohort study
por: Futami, Shinji, et al.
Publicado: (2018) -
Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis
por: Hirose, Masaki, et al.
Publicado: (2019) -
Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis
por: Sakurai, Teiko, et al.
Publicado: (2021) -
Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis
por: Katayama, Kanako, et al.
Publicado: (2020) -
Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody
por: Arai, Toru, et al.
Publicado: (2020)